Difficulty: Medium
Average Score: 65%
Practice
Which of the following agents might mask the hypoglycemic reaction in treated diabetic patients?
Correct answer
D
Rationale
In this question, the correct answer is option D) Beta-adrenergic antagonists. Beta-adrenergic antagonists, also known as beta-blockers, can mask the signs and symptoms of hypoglycemia in diabetic patients. This is because beta-blockers can inhibit the typical adrenergic response to low blood sugar, such as palpitations, tremors, and sweating, which are important warning signs for diabetic patients to detect hypoglycemia.
Option A) Beta-adrenergic agonists would not mask hypoglycemic reactions but rather can exacerbate them by stimulating the adrenergic response, leading to increased heart rate and potential for further hypoglycemia.
Option B) Alpha-adrenergic antagonists and Option C) Alpha-adrenergic agonists are not directly related to masking hypoglycemic reactions in diabetic patients. These agents primarily affect alpha-adrenergic receptors and are not involved in the counter-regulatory response to hypoglycemia.
Understanding the effects of different classes of drugs on diabetic patients is crucial for healthcare professionals, especially when managing their medications. Knowing how beta-blockers can impact hypoglycemic symptoms is essential to ensure proper monitoring and management of blood glucose levels in diabetic patients taking these medications. This knowledge can prevent delays in recognizing and treating hypoglycemia, ultimately improving patient safety and outcomes.
Option A) Beta-adrenergic agonists would not mask hypoglycemic reactions but rather can exacerbate them by stimulating the adrenergic response, leading to increased heart rate and potential for further hypoglycemia.
Option B) Alpha-adrenergic antagonists and Option C) Alpha-adrenergic agonists are not directly related to masking hypoglycemic reactions in diabetic patients. These agents primarily affect alpha-adrenergic receptors and are not involved in the counter-regulatory response to hypoglycemia.
Understanding the effects of different classes of drugs on diabetic patients is crucial for healthcare professionals, especially when managing their medications. Knowing how beta-blockers can impact hypoglycemic symptoms is essential to ensure proper monitoring and management of blood glucose levels in diabetic patients taking these medications. This knowledge can prevent delays in recognizing and treating hypoglycemia, ultimately improving patient safety and outcomes.